Add BrightSurf on Google Email

Johns Hopkins Medicine


Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins

Scientists at Johns Hopkins Medicine have overcome a major obstacle to creating large libraries of drug-like peptides. By modifying naturally occurring amino acids with a methyl group, they can produce up to 10 billion stabilized peptides in a single reaction. This breakthrough enables the rapid testing of potential medicines and has s...

SourceJohns Hopkins Medicine·JournalChemistry & Biology·DateApr 22, 2004

Crowding stem cells' personal space directs their future

Researchers at Johns Hopkins Medicine found that mesenchymal stem cell shape is a critical factor in determining which type of cell they will become. By using micropatterning technology, the team showed that spherical stem cells efficiently transform into fat cell precursors, while those allowed to stretch and flatten move closer to be...

SourceJohns Hopkins Medicine·JournalDevelopmental Cell·DateApr 16, 2004

Gaining health while giving back to the community

The study found that Experience Corps volunteers experienced increased physical, cognitive, and social activity, which could lead to improved health outcomes. Volunteers also reported feeling stronger and had a reduced need for canes. In contrast, the control group showed a decline in social activity and an increase in TV viewing.

SourceJohns Hopkins Medicine·JournalJournal of Urban Health·DateApr 6, 2004

Genetic mutation linked to infant lung disease

A genetic mutation in the ABCA3 gene is linked to severe surfactant deficiency in infants, leading to fatal lung disease. Researchers found mutations in 16 infants, with 15 dying from their illness, and discovered a potential mechanism for the defective transport of phospholipids critical for surfactant function.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateMar 24, 2004

Combination of toxin and poison may be novel treatment for leukemia

Scientists at Johns Hopkins Medicine have found that a low-dose combination of arsenic and bryostatin can kill APL cell lines by activating the cancer cells' natural self-destruct mechanism. This therapy has potential for treating treatment-resistant acute promyelocytic leukemia, a subtype of acute myeloid leukemia with poor outcomes.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateMar 15, 2004

Hopkins researchers find MRI useful tool in diagnosing inflammatory bowel diseases in children

A study published in Inflammatory Bowel Diseases found that gadolinium-enhanced MRI (G-MRI) was highly accurate in diagnosing inflammatory bowel disease (IBD) in children, with 92% accuracy for ulcerative colitis and 96% accuracy for Crohn's disease. This non-invasive diagnostic tool could replace conventional tests like colonoscopy.

SourceJohns Hopkins Medicine·JournalInflammatory Bowel Diseases·DateMar 4, 2004

Patients give nod to kidney dialysis at home

A study by Johns Hopkins researchers found that patients on peritoneal dialysis rate their care as excellent, citing independence, access to staff, and quality of treatment. In contrast, hemodialysis patients report lower satisfaction rates, with many citing inadequate information and economic factors as barriers.

SourceJohns Hopkins Medicine·JournalJAMA·DateFeb 10, 2004

Inflammation marker predicts colon cancer

A study published in The Journal of the American Medical Association found that people with higher CRP levels were more likely to develop colorectal cancers over an 11-year period. Median CRP levels were higher among those who developed colon cancer, and inflammation was linked to increased risk without being mediated by diabetes.

SourceJohns Hopkins Medicine·JournalJAMA·DateFeb 3, 2004

'HapMap' scientists provide detailed plans

The HapMap project aims to create a catalog of common genetic patterns, or haplotypes, which will simplify and accelerate efforts to identify genes associated with chronic diseases. By analyzing DNA samples from over 270 individuals from four countries, the project hopes to provide insights into human genetics.

SourceJohns Hopkins Medicine·JournalNature·DateDec 18, 2003

Key appetite regulator may be identified, scientists report

Researchers at Johns Hopkins Medicine have identified malonyl-CoA as a key chemical regulator of appetite in mice. By injecting the compound C75 into the brain, they found that levels of malonyl-CoA increase immediately after feeding, triggering appetite signals. This breakthrough understanding could lead to new ways to control appetite.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateDec 18, 2003

Origin of multiple myeloma found in rare stem cell

Researchers at Johns Hopkins Medicine discovered a rare stem cell in multiple myeloma that gives rise to malignant bone marrow plasma cells. Current treatments may not be effective against this errant stem cell, leading scientists to explore dual-therapy approaches to target both the visible and root causes of the disease.

SourceJohns Hopkins Medicine·JournalBlood·DateDec 3, 2003

Whites, African-Americans better rate medical care experiences when seeing same-race physicians

A new study by Johns Hopkins Medicine found that patients who see the same race physician have longer visits and higher satisfaction ratings. The longer visit times may be due to patients speaking slower when they feel more comfortable with their physician's background, which can lead to better communication and patient experiences.

SourceJohns Hopkins Medicine·JournalAnnals of Internal Medicine·DateDec 3, 2003

Stents combined with clot-busting drugs effective in limiting impact of deadly form of stroke

Researchers found that four out of six patients treated with stents and tPA experienced permanent improvement in neurologic symptoms, while two critically ill patients died due to large clots. The study suggests a combined treatment approach may offer superior results for most patients with acute vertebrobasilar ischemic strokes.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Neuroradiology·DateNov 11, 2003